PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Mar-2023 Antev Receives US FDA Guidance on Teverelix® Phase 3 Trial Design for Treating Advanced Prostate Cancer Patients with Increased Cardiovascular Risk Antev Ltd
09-Mar-2023 Cancer Research UK Signs Multi-Project Collaboration With UCB To Advance Oncology Antibody Candidates UCB
09-Mar-2023 Merck’s MK-0616 holds potential to become first oral PCSK9 inhibitor in dyslipidemia market, says GlobalData GlobalData
09-Mar-2023 IIVS will offer ToxTracker®, expanding its portfolio of animal-free genetic toxicology assays Institute for In Vitro Sciences (IIVS)
09-Mar-2023 Labels with temperature and light indicators for easy and safe use Faller Packaging
09-Mar-2023 IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation B3C newswire
09-Mar-2023 Francis Crick Institute to open ‘Skylab’ space for scientific partnerships Francis Crick Institute
09-Mar-2023 Moberg Pharma regains full rights to MOB-015 in Japan Moberg Pharma
09-Mar-2023 Vetter Strengthens Worldwide Commitment to Sustainable Business Practices Vetter
09-Mar-2023 Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference Biophytis
09-Mar-2023 APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary calculations APONTIS PHARMA AG
09-Mar-2023 Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023 Drägerwerk AG & Co. KGaA
09-Mar-2023 Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile Evolva Holding SA
09-Mar-2023 AEVIS VICTORIA SA – AEVIS VICTORIA achieved consolidated revenues of CHF 1.143bn in 2022, up 27.8% (CHF 895.0m) from prior year. AEVIS VICTORIA SA
08-Mar-2023 Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG BRAIN Biotech AG
08-Mar-2023 Vetter Strengthens Worldwide Commitment to Sustainable Business Practices B3C newswire
08-Mar-2023 Essex Bio-Technology Announces 2022 Annual Financial Results Essex Bio-Technology Limited
08-Mar-2023 RDD Europe 2023 Returns In-Person May 2-5, Co-Organized by Aptar Pharma and RDD Online Aptar Pharma
08-Mar-2023 “Where best partners meet”: OPTIMA pharma at Interpack 2023 Optima Pharma
08-Mar-2023 Tiziana Life Sciences Announces Publication in Proceedings of the National Academy of Sciences (PNAS) Illustrating the Immunological Basis of the Mechanism of Action for Intranasal Foralumab Tiziana Life Sciences